Gut Registry

comparison · release 2026-09-20

Visbiome vs Alfasigma USA VSL#3 Capsules

Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.

Available axes

Side-by-side release fields

Each side retains its own unit and denominator. Entity evidence and containing-label observations do not imply a product score or a head-to-head efficacy finding.

Visbiome

product

Axis 1 · traceability

A1: Not available in this release.. Identity: Not available in this release.; quantity disclosure: Not available in this release.; potency: Not available in this release.. No exact DSLD label record was resolved for this named canary in the release snapshot; organism list unavailable.

Axis 2 · evidence

A2: no applicable score. Evidence amount: Not available in this release.; PubMed RCT records: undefined: Not available in this release.; direction balance: The direction of the study results has not been extracted.

Axis 3 · measurement integrity

Not a measurement product, so this axis does not apply.

Axis 4 · observed review panel

undefined: no review panel matched this side.

Preference-dependent summary and price

GIS: no aggregate entity score. Price: undefined: no observation in this release. Observed: undefined: observation date unavailable.

Alfasigma USA VSL#3 Capsules

product

Axis 1 · traceability

A1: 15.00. Identity: Only the species or an unresolved identity is available.; quantity disclosure: 0.0%; potency: The potency basis is not stated..

Axis 2 · evidence

A2: 100.00. Evidence amount: 1.00; PubMed RCT records: 1334; direction balance: The direction of the study results has not been extracted.

Axis 3 · measurement integrity

Not a measurement product, so this axis does not apply.

Axis 4 · observed review panel

undefined: no review panel matched this side.

Preference-dependent summary and price

GIS: 61.75. Price: undefined: no observation in this release. Observed: undefined: observation date unavailable.

Elsewhere in this release

Related pages

Findings computed over the whole corpus: La14 vs ncfm identifiers · Strain naming census

Tools: Unit value calculator

Citation

Cite this page

Ivitskiy, I. (2026). Visbiome vs Alfasigma USA VSL#3 Capsules. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/vs/visbiome-vs-vsl-3-capsules/

The underlying tables are published under CC BY 4.0: this page as CSV · as JSON · full release and data dictionary. Cell-level provenance names the source record and its observation date.

Citable atoms

Release claims

  1. Visbiome prints strain designations for 0 of 0 observed organisms (undefined: no observations), compared with 0 of 8 (0.0%) for Alfasigma USA VSL#3 Capsules. Window: NIH DSLD snapshot Sep 2026.

    0 / 0 organism rows · NIH DSLD snapshot Sep 2026 · comparison.naming · checked 2026-09-20T00:00:00Z · snapshot b7633f732437
  2. Visbiome states through_expiry on 0 of 0 observed labels (undefined: no observations), compared with 0 of 1 (0.0%) for Alfasigma USA VSL#3 Capsules. Window: NIH DSLD snapshot Sep 2026.

    0 / 0 observed label versions · NIH DSLD snapshot Sep 2026 · comparison.potency · checked 2026-09-20T00:00:00Z · snapshot b7633f732437
  3. Visbiome: Not yet queried in this release. Alfasigma USA VSL#3 Capsules: 1334 PubMed record matches across 7 printed-entity queries (query dates: 2026-09-15). Records may overlap across these ingredient queries; this is not a product trial count.

    Alfasigma USA VSL#3 Capsules PubMed query: bifidobacterium-breveAlfasigma USA VSL#3 Capsules PubMed query: bifidobacterium-longumAlfasigma USA VSL#3 Capsules PubMed query: lacticaseibacillus-paracaseiAlfasigma USA VSL#3 Capsules PubMed query: lactiplantibacillus-plantarumAlfasigma USA VSL#3 Capsules PubMed query: lactobacillus-acidophilusAlfasigma USA VSL#3 Capsules PubMed query: lactobacillus-delbrueckiiAlfasigma USA VSL#3 Capsules PubMed query: streptococcus-thermophilus

    Not yet queried in this release. / Not available in this release. PubMed records in the union of both compared entries · NIH DSLD snapshot Sep 2026 · comparison.evidence · checked 2026-09-20T00:00:00Z · snapshot b7633f732437
  4. 0 of 2 compared entries have a numeric price: Visbiome, No numeric price observation is available in this release.; Alfasigma USA VSL#3 Capsules, No numeric price observation is available in this release.. Window: NIH DSLD snapshot Sep 2026.

    0 / 2 compared entries · NIH DSLD snapshot Sep 2026 · comparison.price · checked 2026-09-20T00:00:00Z · snapshot b7633f732437

Back to the release hub